Login



Forget your password?

Patient stories

Read how patients with different types of insurance coverage can lower their out-of-pocket prescription drug costs.

One solution to a Medicare coverage gap

About Bill
Bill has Standard Medicare Part D , and ever since he reached the coverage gap, he has been struggling to pay for his dialysis-related prescriptions. Bill wasn't sure how he was going to survive the "donut hole" financially.

How Renassist® helped Bill and his social worker
When Bill's social worker called Renassist to verify Bill's coverage , she discovered that Bill qualified for Low-Income Subsidy (Extra Help). Extra Help lowered Bill's prescription copay costs considerably—his Renvela® (sevelamer carbonate) copay alone went from $45/fill to $8.25/fill. What's more, Bill's doctor changed many of Bill's prescriptions from 30- to 90-day supplies. As a result, Bill's out-of-pocket costs for his Renvela prescription dropped from $540/year to $33 a year!

Bill is not an actual patient.

A prior authorization doesn't have to be a pain

About Alice
Alice's state's Medicaid plan required a prior authorization for Renvela® (sevelamer carbonate), but Alice felt intimidated by this extra step and asked her social worker for help.

How Renassist® helped Alice and her social worker
Alice's social worker called Renassist and got her prior authorization approved by her insurance company on her behalf. Alice now fills her Renvela® prescription at her local pharmacy for less than $5 a month.

Alice is not an actual patient.

When commercial coverage doesn't cut it

About Joe
Joe has a commercial prescription insurance plan, but the $175 copay for Renvela® (sevelamer carbonate), along with his other out-of-pocket medical costs, was quickly emptying his savings account.

How Renassist® and the RenValueSM coupon program helped Joe
Joe called Renassist and found out he is eligible for the RenValue coupon program because he has commercial insurance. Joe now pays $5 for each Renvela® fill—giving him a yearly savings of over $2,000 ! Now Joe feels more confident he will be able to manage his budget.

Joe is not an actual patient.

When commercial coverage doesn't cover enough

About Carolyn
Carolyn has commercial prescription insurance , but the $50 copay for her Renvela® (sevelamer carbonate) prescription was a hardship. Some months, Carolyn felt like she had to choose between filling her prescription and paying her electric bill.

How the RenValueSM coupon program helped Carolyn
Carolyn's social worker suggested the RenValue coupon program and helped her access the online form to print her coupon. Carolyn now pays only $5 for each fill—giving her a yearly savings of $540 !

Carolyn is not an actual patient.

Being without drug coverage does not mean being without options

About Mike
Mike had health insurance, but his plan did not include prescription drug coverage. When Mike learned about all the prescriptions he would need to take once he started dialysis, he was worried he wouldn't be able to afford it.

How Renassist® helped Mike
Mike read about the Renassist Patient Assistance Program online and completed the application right away. Mike qualified for the program and received a 90-day supply of Renvela® (sevelamer carbonate) at no cost.

Mike is not an actual patient.

Watch Eric's Story

Eric shares his story of life on dialysis and how programs like Renassist helps him save on the medications he needs to help manage his disease.

Get the form

You only need one form to get started.
Download it now

Visit our website
Visit our website
Click here for Ferrlecit Important Safety Information and Full Prescribing Information

Visit our website
Click here for Hectorol Important Safety Information and Full Prescribing Information

Indication
Renvela® (sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.

Renagel® (sevelamer hydrochloride) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis

Important Safety Information
  • Sevelamer is contraindicated in patients with bowel obstruction and in patients with known hypersensitivity to sevelamer carbonate or sevelamer hydrochloride or to any of the excipients.
  • Caution should be exercised in patients with dysphagia, swallowing disorders, and severe gastrointestinal (GI) motility disorders, including severe constipation or major GI tract surgery.
  • Common adverse events reported with sevelamer include vomiting, nausea, diarrhea, dyspepsia, abdominal pain, flatulence, and constipation. Other events reported include pruritus, rash, fecal impaction and, less commonly, ileus, bowel obstruction, and bowel perforation.
  • Uncommon cases of difficulty swallowing the Renagel or Renvela tablet have been reported. Caution should be exercised in these patients and consideration given to using Renvela suspension in patients with a history of difficulty swallowing.
  • Drug-drug interactions may occur with some medications and should be taken into consideration when instructing patients how to take sevelamer.
  • Serum bicarbonate and chloride levels should be monitored.
  • Follow patients for reduced vitamins D, E, and K (coagulation parameters) and folic acid levels.
  • Patients should be informed to take sevelamer with meals and to adhere to their prescribed diets.

Please click here for Full Prescribing Information for Renvela (PDF) or here for Full Prescribing Information for Renagel (PDF).

Indication
Renvela® (sevelamer carbonate) and Renagel® (sevelamer hydrochloride) are used to control phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

Important Safety Information
  • Do not use sevelamer if you have a history of bowel obstruction.
  • Talk to your doctor if you have had difficulty swallowing or swallowing disorders; or if you have had digestive tract surgery or other digestive disorders, including severe constipation.
  • The most common side effects with sevelamer include vomiting, nausea, diarrhea, upset stomach, abdominal pain, flatulence, and constipation.
  • Cases of itching, rash, fecal impaction and, less commonly, slow bowel activity, bowel obstruction, and bowel perforation have been reported.
  • Uncommon cases of difficulty swallowing the Renagel or Renvela tablet have been reported. Talk to your doctor if you have difficulty swallowing medicines in tablet form. Renvela powder for oral suspension may be considered by your doctor if you have a history of difficulty swallowing.
  • Your doctor should monitor bicarbonate and chloride blood levels.
  • Reduced vitamins D, E, and K (clotting factors) and folic acid blood levels may be followed by your doctor.
  • Talk to your doctor when taking sevelamer with other medications.
  • Promptly contact your doctor if you experience severe abdominal pain, new or worsening constipation, or other severe intestinal symptoms while on sevelamer.
  • Take sevelamer with meals and adhere to your prescribed diet.

Please click here for Full Prescribing Information for Renvela (PDF) or here for Full Prescribing Information for Renagel (PDF).

    Terms and conditions  |  Privacy policy  |  Prescribing Information for Renvela®  |  Prescribing Information for Renagel®  |  Contact Renassist  |  Resources